Kitazato

Kitazato Long-term Debt

The Long-Term Debt of Kitazato (368A.T) as of Nov 17, 2026 is 78.00 M JPY. In the previous year, Long-Term Debt was 121.00 M JPY — a change of -35.54% (lower).

Long-term Debt

78.00 MJPY

YoY

-35.54%

Last updated:

Long-Term Debt of Kitazato is 2025 78.00 M JPY. Long-Term Debt of Kitazato was 2024 121.00 M JPY. It decreases by -35.54% lower compared to the previous year.

The Kitazato Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2023
99.00 M JPY
Jan 1, 2024
121.00 M JPY
Jan 1, 2025
78.00 M JPY
The Kitazato Long-term Debt history
YEARLong-term DebtYoY
78.00 MJPY-35.54%
121.00 MJPY+22.22%
99.00 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Long-Term Debt of Kitazato is 78.00 M JPY in 2025.

Long-Term Debt of Kitazato changed from 121.00 M JPY to 78.00 M JPY, representing a -35.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Kitazato since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Kitazato historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Kitazato

All Key Metrics — Kitazato